135.00p
0.00%
Close of 9 Nov 2026, in pence
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Aoti
Its shares trade on LSE under the ticker AOTI.L. It has been listed since 18 June 2024. In the fiscal year to 31 December 2025, it reported revenue of $68.8m and net income of $2.8m. At that date it held total assets of $57.0m and shareholders' equity of $19.9m.
Aoti Inc is a US-based company operating in industry. The company is headquartered in Oceanside, California. The company went IPO on 2024-06-18. Aoti, Inc. is engaged in wound care technology around the world. The firm is focused on helping all people with chronic conditions get back to living their lives to the fullest. The company does this by enhancing access to care, improving clinical outcomes and quality of life, and advancing health equity. Its products are built with integrity and backed by robust clinical evidence, ensuring safety and efficacy for its patients. Its solutions include Topical Wound Oxygen (TWO2) and NEXA Negative Pressure Wound Therapy (NPWT). TWO2 therapy is a multi-modality patient-administered therapy. TWO2 is a clinically proven therapy for the treatment of chronic and difficult-to-heal wounds. The NEXA NPWT System is a multi-week, multi-patient, disposable system that delivers the performance and flexibility of traditional NPWT systems. TWO2 therapy solutions include TWO2 Extremity Chamber and TWO2 Multi-Patch.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- N/A
- Industry
- N/A
- Listed since
- 18 Jun 2024
- Website
- aotinc.net ↗
Leadership
Pay as last reported
- Mr. Douglas Le FortNon-Executive Chairman of the Board
- Dr. Michael GriffithsChief Executive Officer, Executive Director, since 2008
- Mr. Jayesh PankhaniaChief Financial Officer, Executive Director, since 2024
- Mr. Anthony MoffattChief Operating Officer
- Mr. Anthony BourneIndependent Non-Executive Director
- Mr. Richard CottonSenior Independent Non-Executive Director
- Dr. Ceri MorganIndependent Non-Executive Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Aoti Inc has a focused industry in wound care technology with products like TWO2 and NEXA NPWT.
- The company emphasizes clinical evidence and safety for its products.
- Aoti Inc's solutions aim to improve clinical outcomes and quality of life for patients.
Weaknesses
- The company's sector and industry are listed as N/A in the provided data.
- Aoti Inc is a newly listed company with an IPO date of 2024-06-18.
- The company's website is provided but no additional details about its market presence are given.
Opportunities
- The company can expand its market presence in the global wound care technology sector.
- Growing demand for chronic condition management solutions presents an opportunity.
- Advancing health equity through wound care technology could attract new partnerships.
Threats
- The company's unverified industry focus may lead to market confusion.
- As a new IPO, Aoti Inc faces challenges in establishing market credibility.
- Competition in the wound care technology sector could impact market share.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.